Janice Elizabeth Contreras, MD | |
301 University Blvd, Galveston, TX 77555-5302 | |
(409) 772-2222 | |
Not Available |
Full Name | Janice Elizabeth Contreras |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 21 Years |
Location | 301 University Blvd, Galveston, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295933158 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | M6575 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Texas Medical Branch Galveston | Galveston, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Texas Medical Branch Faculty Group Practice | 3375456734 | 875 |
News Archive
Researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved a mystery surrounding the novel coronavirus pandemic: Why men infected by the virus generally show more severe symptoms and are more likely than women to die from COVID-19.
A report by the World Hepatitis Alliance has called for an increased focus on hepatitis and says the disease should be given the same attention as AIDS, tuberculosis and malaria.
The U.S. Food and Drug Administration has approved a viral melanoma therapy that was the focus of a phase III clinical trial led by Rutgers Cancer Institute of New Jersey Associate Director for Clinical Science and Chief Surgical Officer Howard L. Kaufman, MD, FACS.
Genetic research conducted at LSU Health New Orleans School of Medicine and Stanley S. Scott Cancer Center demonstrated for the first time that a novel protein can cause normal cells in the lining of the colon to become malignant, grow and spread, as well as take on the characteristics of stem cells.
Pharming Group N.V. announced today the positive results from a key study with recombinant human lactoferrin (rhLF). The Company will use these results for Generally Regarded as Safe (GRAS) registration of rhLF for nutritional applications.
› Verified 4 days ago
Entity Name | Utmb Faculty Group Practice |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942241146 PECOS PAC ID: 3375456734 Enrollment ID: O20031112000438 |
News Archive
Researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved a mystery surrounding the novel coronavirus pandemic: Why men infected by the virus generally show more severe symptoms and are more likely than women to die from COVID-19.
A report by the World Hepatitis Alliance has called for an increased focus on hepatitis and says the disease should be given the same attention as AIDS, tuberculosis and malaria.
The U.S. Food and Drug Administration has approved a viral melanoma therapy that was the focus of a phase III clinical trial led by Rutgers Cancer Institute of New Jersey Associate Director for Clinical Science and Chief Surgical Officer Howard L. Kaufman, MD, FACS.
Genetic research conducted at LSU Health New Orleans School of Medicine and Stanley S. Scott Cancer Center demonstrated for the first time that a novel protein can cause normal cells in the lining of the colon to become malignant, grow and spread, as well as take on the characteristics of stem cells.
Pharming Group N.V. announced today the positive results from a key study with recombinant human lactoferrin (rhLF). The Company will use these results for Generally Regarded as Safe (GRAS) registration of rhLF for nutritional applications.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Janice Elizabeth Contreras, MD 301 University Blvd, Galveston, TX 77555-5302 Ph: (409) 772-2222 | Janice Elizabeth Contreras, MD 301 University Blvd, Galveston, TX 77555-5302 Ph: (409) 772-2222 |
News Archive
Researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved a mystery surrounding the novel coronavirus pandemic: Why men infected by the virus generally show more severe symptoms and are more likely than women to die from COVID-19.
A report by the World Hepatitis Alliance has called for an increased focus on hepatitis and says the disease should be given the same attention as AIDS, tuberculosis and malaria.
The U.S. Food and Drug Administration has approved a viral melanoma therapy that was the focus of a phase III clinical trial led by Rutgers Cancer Institute of New Jersey Associate Director for Clinical Science and Chief Surgical Officer Howard L. Kaufman, MD, FACS.
Genetic research conducted at LSU Health New Orleans School of Medicine and Stanley S. Scott Cancer Center demonstrated for the first time that a novel protein can cause normal cells in the lining of the colon to become malignant, grow and spread, as well as take on the characteristics of stem cells.
Pharming Group N.V. announced today the positive results from a key study with recombinant human lactoferrin (rhLF). The Company will use these results for Generally Regarded as Safe (GRAS) registration of rhLF for nutritional applications.
› Verified 4 days ago
Kevin H Merkley, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 700 University Blvd, Galveston, TX 77555 Phone: 409-747-5400 Fax: 409-747-5402 | |
Dr. Susan Elizabeth Azar, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 700 University Blvd, Galveston, TX 77550 Phone: 409-772-5800 Fax: 409-772-5825 | |
Dr. Gerardo David Camoriano Nolasco, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: University Of Texas Medical Branch-ophthalmology, 301 University Blvd, Galveston, TX 77555 Phone: 409-747-5801 | |
Touka Banaee, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: Eye Center 700 University Blvd, Galveston, TX 77555 Phone: 409-747-5800 Fax: 409-747-5825 | |
Mehreen Idrees Adhi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 700 University Blvd, Galveston, TX 77550 Phone: 409-772-5800 Fax: 409-772-5825 | |
Frank J Holzapfel, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 |